Newsroom
Why Scalable AI in Life Sciences Starts with Data Systems, Not Algorithms
Artificial intelligence continues to gain momentum across the life sciences industry. Organizations are exploring AI to accelerate clinical development, improve quality and compliance processes, optimize manufacturing and supply chains, and enhance commercial effectiveness.
Where AI is Working in Clinical R&D
Sandy Tammisetty, VP of Veeva Services Practice Group at Conexus Solutions, spoke with Pharmaceutical Executive about where AI implementation is working for the pharma industry, and where it doesn’t appear to be a good fit.
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Sunitha Venkat, vice president of data services and insights at Conexus Solutions, spoke with Pharmaceutical Executive about the importance of using high quality data visualization methods.
The Future of AI in Biotech: From Experimentation to Impact
Sunitha Venkat, VP of Data Services & Insights at Conexus Solutions, shares her perspective on what it takes to move AI in biotech from experimentation to scalable, compliant impact, with a focus on data foundations, governance, and cross-functional alignment.
Regulating AI: Establishing governance to control an unstoppable force
AI technologies have captured the public imagination and burst into the cultural zeitgeist. Whether through interactive chat programs or AI-generated images, videos, and songs, most of us have witnessed AI’s growth in performing tasks traditionally credited to humans.
Reengineering Medical Devices: Innovation, Oversight, and the GxP Imperative
The medical device industry is undergoing a seismic transformation. From orthopedic implants and diagnostic platforms to surgical instruments and digital health solutions, innovation is surging, but so is complexity.
The Bottleneck in Biotech Isn’t AI Technology — It’s Trust
In an effort to optimize operations and maximize efficiency, many biotechnology and pharmaceutical companies are looking to integrate AI into their R&D workflows.
Reimagining How AI Is Reshaping Discovery, Development and Commercialization
Rising R&D costs, extended development timelines, and increasingly complex regulatory environments have created immense pressure on biopharma organisations to innovate faster while delivering more value to patients and stakeholders.
Optimizing Life Sciences CRM: A Candid Conversation with Akshay Kapadia from Conexus Solutions
As life sciences organizations increasingly adopt integrated data, AI, and advanced analytics, CRM platforms are becoming powerful tools to anticipate customer needs, personalize engagements, and measure impact in real-time across multiple channels.